[go: up one dir, main page]

NO20075323L - Ernaeringspreparat for HIV-pasienter - Google Patents

Ernaeringspreparat for HIV-pasienter

Info

Publication number
NO20075323L
NO20075323L NO20075323A NO20075323A NO20075323L NO 20075323 L NO20075323 L NO 20075323L NO 20075323 A NO20075323 A NO 20075323A NO 20075323 A NO20075323 A NO 20075323A NO 20075323 L NO20075323 L NO 20075323L
Authority
NO
Norway
Prior art keywords
hiv patients
nutritional preparation
nutritional
preparation
hiv
Prior art date
Application number
NO20075323A
Other languages
English (en)
Inventor
Eric Alexander Franciscus Tol
Johan Garssen
Johannes Wilhelmus Chri Sijben
George Veerlaan
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34939443&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20075323(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of NO20075323L publication Critical patent/NO20075323L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Det beskrives et ernæringsprodukt for HIV-pasienter som ikke er på sterkt aktiv anti-retroviral terapi. Nærmere bestemt beskrives en ernæringssammensetning omfattende oligosaccarider. Oppfinnelsen vedrører også en fremstilling av et ernæringssupplement for anvendelse i HIV-pasienter.
NO20075323A 2005-04-21 2007-10-17 Ernaeringspreparat for HIV-pasienter NO20075323L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67334205P 2005-04-21 2005-04-21
EP05103260A EP1721611A1 (en) 2005-04-21 2005-04-21 Nutritional supplement with oligosaccharides for a category of HIV patients
PCT/NL2006/050092 WO2006112717A2 (en) 2005-04-21 2006-04-19 Nutritional supplement for a category of hiv patients

Publications (1)

Publication Number Publication Date
NO20075323L true NO20075323L (no) 2008-01-21

Family

ID=34939443

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075323A NO20075323L (no) 2005-04-21 2007-10-17 Ernaeringspreparat for HIV-pasienter

Country Status (14)

Country Link
US (1) US20090082249A1 (no)
EP (2) EP1721611A1 (no)
JP (1) JP2008536915A (no)
CN (1) CN101262783A (no)
AR (1) AR054256A1 (no)
AU (1) AU2006237739A1 (no)
BR (1) BRPI0610784A2 (no)
CA (1) CA2605210A1 (no)
MX (1) MX2007013082A (no)
NO (1) NO20075323L (no)
NZ (1) NZ562666A (no)
RU (1) RU2007143060A (no)
WO (1) WO2006112717A2 (no)
ZA (1) ZA200709047B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
AU2003251715A1 (en) * 2002-08-30 2004-03-19 Campina B.V. Foaming ingredient and products containing the ingredient
EP1597978A1 (en) * 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
EP1758469B2 (en) * 2004-06-22 2013-09-25 N.V. Nutricia Improvement of barrier integrity in hiv patients by use of fatty acids
EP1723951A1 (en) * 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
RU2421077C2 (ru) * 2005-04-21 2011-06-20 Н.В. Нютрисиа Пищевая добавка для пациентов с вич (варианты)
WO2008156354A1 (en) * 2007-06-21 2008-12-24 N.V. Nutricia Modulation of intestinal flora of hiv patients
WO2009096772A1 (en) 2008-02-01 2009-08-06 N.V. Nutricia Composition for stimulating natural killer cell activity
SG191799A1 (en) 2010-12-31 2013-08-30 Abbott Lab Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
NZ612455A (en) 2010-12-31 2015-02-27 Abbott Lab Human milk oligosaccharides to promote growth of beneficial bacteria
ES2719404T5 (es) 2010-12-31 2024-09-18 Abbott Lab Composiciones nutricionales que comprenden oligosacáridos de leche humana para el uso en el tratamiento y/o prevención de la infección por rotavirus entérico
ES2708924T3 (es) 2010-12-31 2019-04-12 Abbott Lab Procedimientos de uso de oligosacáridos de la leche humana para mejorar la salud respiratoria de las vías respiratorias
EP2658549B1 (en) 2010-12-31 2020-06-03 Abbott Laboratories Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
MY171620A (en) 2010-12-31 2019-10-21 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers or children using human milk oligosaccharides
MX375120B (es) 2010-12-31 2025-03-06 Abbott Lab Oligosacáridos de leche humana para modular la inflamación.
WO2012177118A1 (en) * 2011-06-22 2012-12-27 N.V. Nutricia Method for reducing the occurrence of infection in young children
BR112014001472A2 (pt) 2011-07-22 2017-02-21 Abbott Lab galactooligossacarídeos para prevenir lesões e / ou promover a cicatrização do trato gastrointestinal
HK1199607A1 (en) 2011-08-29 2015-07-10 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
US9968123B2 (en) 2014-03-26 2018-05-15 Abbott Laboratories Nutritional supplement powder
US10912323B2 (en) 2016-02-29 2021-02-09 Abbott Laboratories Nutritional supplement powder

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2981629A (en) * 1960-04-05 1961-04-25 Lewis F Ginnette Process of dehydrating foams
US4237118A (en) * 1972-03-06 1980-12-02 Howard Alan N Dietary supplement and dietary methods employing said supplement for the treatment of obesity
JPS5645951B2 (no) * 1973-05-21 1981-10-29
FR2490496A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
US4438147A (en) * 1982-06-25 1984-03-20 Societe D'assistance Technique Pour Produits Nestle S.A. Foaming creamer and method of making same
DE3734962C1 (de) * 1987-10-15 1989-01-05 Luitpold Werk Chem Pharm Verwendung von Chondroitinpolysulfat zur vorbeugenden,lindernden oder heilenden Behandlung von AIDS und ARC
JPH01149730A (ja) * 1987-12-07 1989-06-12 Osaka Prefecture レトロウイルス増殖抑制剤
ES2053953T3 (es) * 1988-08-24 1994-08-01 Akzo Nv Uso de fracciones de heparina o fragmentos de heparina.
JP2782443B2 (ja) * 1988-12-26 1998-07-30 將純 吉原 抗エイズウィルス剤
ES2033193B1 (es) * 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
ATE200619T1 (de) * 1991-01-24 2001-05-15 Martek Corp Mikrobielle öle und ihre verwendungen
FR2673812B1 (fr) * 1991-03-13 1994-04-01 Roussel Uclaf Nouvelles compositions destinees a etre utilisees en dietetique et en therapeutique et renfermant une combinaison particuliere de glucides et leurs applications.
JPH04300888A (ja) * 1991-03-28 1992-10-23 Dainippon Ink & Chem Inc カルボン酸オリゴ糖エステル硫酸化物
IT1248060B (it) * 1991-06-14 1995-01-05 Italfarmaco Spa Eparine acilate come inibitori della replicazione di retrovirus
US5629023A (en) * 1991-12-31 1997-05-13 Bland; Jeffrey S. Medical food composition for metabolic detoxification
US5502041A (en) * 1992-12-11 1996-03-26 The Center For Innovative Technology Potent inhibitor of HIV reverse transcriptase
US5472952A (en) * 1993-03-18 1995-12-05 Bristol-Myers Squibb Company Partially hydrolyzed pectin in nutritional compositions
JP3310738B2 (ja) * 1993-11-10 2002-08-05 株式会社ロッテ 低カロリーチョコレート
DE4404877C1 (de) * 1994-02-17 1995-03-02 Ksk Industrielackierungen Gmbh Lackierverfahren und zur Durchführung des Verfahrens geeignete Lackgießvorrichtung
US5952314A (en) * 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
US5531988A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Bacteria and immunoglobulin-containing composition for human gastrointestinal health
US5531989A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
JPH08151328A (ja) * 1994-11-28 1996-06-11 Fuji Ratetsukusu Kk エイズ感染防止潤滑剤
US5733579A (en) * 1995-04-05 1998-03-31 Abbott Laboratories Oral rehydration solution containing indigestible oligosaccharides
US20020016289A1 (en) * 1995-06-01 2002-02-07 Orla M. Conneely Methods for treatment and prevention of helicobacter pylori infection using lactoferrin
US5827526A (en) * 1995-07-11 1998-10-27 Abbott Laboratories Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
ES2123903T5 (es) * 1995-08-04 2011-02-22 N.V. Nutricia Composición nutritiva conteniendo fibra.
MY115050A (en) * 1995-10-16 2003-03-31 Mead Johnson Nutrition Co Diabetic nutritional product having controlled absorption of carbohydrate
JPH10108647A (ja) * 1996-10-08 1998-04-28 Meiji Seika Kaisha Ltd 胃切除術後患者用ミネラル補給材
JP4008974B2 (ja) * 1996-12-12 2007-11-14 森永乳業株式会社 ビフィズス菌増殖促進組成物及びその用途
DE19701382A1 (de) * 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
EP1039892B1 (en) * 1997-02-21 2004-04-28 Abbott Laboratories Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis
US5840361A (en) * 1997-04-09 1998-11-24 Beech-Nut Nutrition Corporation Fructan-containing baby food compositions and methods therefor
NL1005809C2 (nl) * 1997-04-14 1998-10-19 Dsm Nv Poederverfbindmiddelsamenstelling.
US5846569A (en) * 1997-06-20 1998-12-08 Creative Labs, Inc. Colostrum supplement
US6051260A (en) * 1998-04-07 2000-04-18 Healthcomm International, Inc. Medical food composition of reduced allergenicity, especially adapted for improving gut mucosal integrity
FR2781673B1 (fr) * 1998-07-28 2001-09-28 Univ Picardie Utilisation d'un glucuronane en tant qu'agent immunostimulant, procede de preparation
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
US6231889B1 (en) * 1998-09-21 2001-05-15 Chronorx, Llc Unit dosage forms for the treatment of herpes simplex
US6794495B1 (en) * 1998-10-19 2004-09-21 New Nordic Danmark Aps Composition comprising extensin and, optionally, pectic polysaccharides
KR100647057B1 (ko) * 1999-01-28 2006-11-17 소시에떼 데 프로듀이 네슬레 소시에떼아노님 착향의 가용성 크리머 분말
EP1074181A1 (en) * 1999-08-03 2001-02-07 Societe Des Produits Nestle S.A. Foaming creamer ingredient and powders containing it
DE19940011B4 (de) * 1999-08-24 2009-04-02 Schütte/Reichel GbR (vertretungsberechtigte Gesellschafter: Irene Schütte Alginataufbereitung und deren Verwendung
US6737089B2 (en) * 1999-08-27 2004-05-18 Morinda, Inc. Morinda citrifolia (Noni) enhanced animal food product
DE10006989A1 (de) * 2000-02-16 2001-08-23 Nutricia Nv Antiadhäsive Kohlenhydratmischung
US6846501B2 (en) * 2000-04-12 2005-01-25 Mid-America Commercialization Corporation Traditional snacks having balanced nutritional profiles
DE10027050A1 (de) * 2000-06-02 2001-12-13 Karim Balan Alginathaltige Zusammensetzung und deren Verwendung
US6426110B1 (en) * 2000-08-11 2002-07-30 Global Health Sciences, Inc. Low-carbohydrate high-protein creamer powder
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
CN1111541C (zh) * 2000-09-15 2003-06-18 青岛海洋大学 一种聚甘露糖醛酸硫酸盐
DE10057976B4 (de) * 2000-11-22 2005-02-03 Südzucker AG Mannheim/Ochsenfurt Verfahren zur Herstellung von Pektinhydrolyseprodukten
US6511696B2 (en) * 2000-12-13 2003-01-28 Novartis Nutrition Ag Infant formula with free amino acids and nucleotides
CN1457357A (zh) * 2001-02-15 2003-11-19 旭电化工业株式会社 包含β－葡聚糖的制品
AU2003245252A1 (en) * 2002-04-30 2003-11-17 Fmc Corporation Carrageenan based antimicrobial compositions
AU2003251715A1 (en) * 2002-08-30 2004-03-19 Campina B.V. Foaming ingredient and products containing the ingredient
WO2004026259A2 (en) * 2002-09-20 2004-04-01 Griscom Bettle, Iii Transdermal compositions
US6974841B1 (en) * 2002-09-27 2005-12-13 Rapisarda Family Irrevocable Trust Pet anti-aging wellness supplement
US20040219188A1 (en) * 2003-05-02 2004-11-04 Comer Gail M. Composition and methods for nutritional management of patients with hepatic disease
AU2003904192A0 (en) * 2003-08-11 2003-08-21 Adelaide Research and Innovaiton Pty Ltd Method for inhibiting bacterial colonisation
ATE400278T1 (de) * 2003-10-24 2008-07-15 Nutricia Nv Immunmodulierende oligosaccharide
FR2866203B1 (fr) * 2004-02-13 2006-12-08 Roquette Freres Procede de fabrication d'un produit de cuisson a base de gluten
EP1597978A1 (en) * 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) * 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
EP1723951A1 (en) * 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
EP1758469B2 (en) * 2004-06-22 2013-09-25 N.V. Nutricia Improvement of barrier integrity in hiv patients by use of fatty acids
AU2005269887A1 (en) * 2004-07-07 2006-02-09 The General Hospital Corporation Direct activation of ATIII in whole blood and plasma
EP1916908A1 (en) * 2005-07-27 2008-05-07 Cantabria Group LCC Phosphorylated glucomannane polysaccharides containing 1-6 and 1-2 linkages increase weight gain in poultry

Also Published As

Publication number Publication date
MX2007013082A (es) 2008-01-11
CN101262783A (zh) 2008-09-10
WO2006112717A3 (en) 2007-07-12
AR054256A1 (es) 2007-06-13
CA2605210A1 (en) 2006-10-26
JP2008536915A (ja) 2008-09-11
ZA200709047B (en) 2008-09-25
NZ562666A (en) 2011-03-31
EP1721611A1 (en) 2006-11-15
EP1874136A2 (en) 2008-01-09
AU2006237739A1 (en) 2006-10-26
BRPI0610784A2 (pt) 2010-11-09
RU2007143060A (ru) 2009-06-10
WO2006112717A2 (en) 2006-10-26
US20090082249A1 (en) 2009-03-26

Similar Documents

Publication Publication Date Title
NO20075323L (no) Ernaeringspreparat for HIV-pasienter
MY148108A (en) Medicaments for the treatment or prevention of fibrotic diseases
EP1521749B8 (en) PHENYL-(4-(3-PHENYL-1H-PYRAZOL-4-YL)-PYRIMIDIN-2-Yl)-AMINE DERIVATIVES
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
WO2009002867A3 (en) Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
MX2009003372A (es) Formas de dosificacion de pelicula no mucoadhesiva.
CY1108794T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου
NO20081942L (no) Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser
MX2010006204A (es) Derivados de oxindol 5,6-disubstituidos y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
PL1680128T3 (pl) Heksafosforan mio-inozytolu do stosowania miejscowego
NO20084826L (no) Ny administrasjonsform av racecadotril
MX2009013501A (es) Compuestos piperidinicos y sus usos.
TN2009000275A1 (en) Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome
SI1511489T1 (sl) Novi farmacevtski sestavki, ki vsebujejo polimorf A flibanserina
NO20082047L (no) Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme
AU2020278236A8 (en) Methods of treating Sjögren's Syndrome using a Bruton's tyrosine kinase inhibitor
TW200801032A (en) Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders
TW200740429A (en) Methods and dosage forms for reducing side effects of carbamate compounds
NO20092763L (no) Isosorbid mononitrat derivater for behandling av tarmlidelser
PL1994926T3 (pl) Preparaty walsartanu
GEP20125709B (en) Chromane derivatives as trpv3 modulators
DE602007004348D1 (de) Arzneimittel zur behandlung von sarkoglykanopathien
MX2009008813A (es) Composicion farmaceutica que contiene floroglucinol y paracetamol.
EP4442315A3 (en) Lta4h inhibitor for the treatment or prevention of hidradenitis suppurativa
BRPI0516545A (pt) uso de óleo de lavanda para a profilaxia e tratamento de neurastenia, distúrbios de somatização e outras doenças associadas ao estresse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application